Nortran Pharmaceutical -NRT.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Culver who wrote (1070)	4/21/1999 11:10:00 PM
From: Charles Salski	Read Replies (1) of 1185

Hi David, Copied this from another chat group stockhouse.com Symbol: V.NRT Last Trade: 0.950 (-0.040) Nortran Pharmaceuticals Inc. Posted By Subject PostTime (EST) Post ID harbin2 Hoffman-Roche 4/16/99 / 11:27:02 AM 230441 << Previous Thread Next Thread >> The reason Hoffman didn't exercise their option on the 3 anti-arrythmic compounds by the end of March is because they are now considering licencing Nortran's entire anti-arrythmic program which I believe numbers around three hundred compounds. How long the negotiations will take on this one is anyone's guess. These pharmaceutical giants move at glacial speed, but apparently they are very interested. Just because the stock price is sagging doesn't mean the news is bad, people are just impatient which is understandable. Any comments anyone??? Regards, Charles

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next